Estella, ÁGarnacho-Montero, J2023-02-082023-02-082020-04-22http://hdl.handle.net/10668/15587esAdenosine MonophosphateAlanineAntiviral AgentsBetacoronavirusCOVID-19ChloroquineClinical Decision-MakingClinical Trials as TopicCoronavirus InfectionsCost-Benefit AnalysisDrug CombinationsEmpiricismHumansHydroxychloroquineInformation DisseminationLopinavirPandemicsPneumonia, ViralReproducibility of ResultsRitonavirSARS-CoV-2Viral Load[From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic].Del empirismo a la evidencia científica en el tratamiento con antivíricos en los casos graves de infección por coronavirus en tiempos de epidemia.research article32423569open access10.1016/j.medin.2020.04.0092173-5727PMC7174180https://doi.org/10.1016/j.medin.2020.04.009https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174180/pdf